5 assets in Arteriosclerosis Disorder

Therapeutic assets addressing Arteriosclerosis Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dapagliflozin Arteriosclerosis Disorder	University Medical Centre Ljubljana	P4	BBB (73)
Aspirin Arteriosclerosis Disorder	Yonsei University	P4	BB (68)
Apixaban Arteriosclerosis Disorder	Yonsei University	P4	BB (65)
Clopidogrel Arteriosclerosis Disorder	Yonsei University	P4	BB (65)
S-Equol Arteriosclerosis Disorder	Akira Sekikawa	P2	CCC (53)